Tag: automated insulin delivery
Insulet’s data platform now available widely in US
October 28, 2026HME News Staff
ACTON, Mass. – Insulet has announced the full market release of Omnipod Discover, a web-based data platform designed for Omnipod 5 users, their caregivers and health care providers, in the United States. The company says the platform turns diabetes data into clear visualizations and personalized insights, providing a shared understanding of therapy patterns and empowering more informed diabetes management decisions. "The future of diabetes care is not just about generating more data, it's...
Sequel’s twiist approved for adults with inulin-treated Type 2 diabetes
October 20, 2026HME News Staff
MANCHESTER, N.H. – The twiist Automated Insulin Delivery (AID) System has been cleared by the U.S. Food and Drug Administration (FDA) for use in adults over 18 with insulin-treated Type 2 diabetes. The clearance follows twiist's national launch for Type 1 diabetes in March 2026. "For many adults living with Type 2 diabetes, insulin therapy can feel like one more thing to manage in an already busy life," said Sequel CEO and Co-Founder Alan Lotvin, MD. "At Sequel, we believe...
Tandem’s AID cleared for pregnancies complicated by Type 1 diabetes mellitus
April 29, 2026HME News Staff
SAN DIEGO – Tandem Diabetes Care has announced that the U.S. Food and Drug Administration (FDA) has cleared Control-IQ+ automated insulin delivery (AID) technology for use in pregnancy complicated by Type 1 diabetes mellitus. Control-IQ+ powers both insulin delivery systems from Tandem – the t:slim X2 and Tandem Mobi, the first and only commercially available AID systems cleared for use during pregnancy in the United States. “Glycemic goals are tighter during pregnancy,” said...
Sequel Med Tech’s twiist now available nationwide
March 10, 2026HME News Staff
MANCHESTER, N.H. – Sequel Med Tech has announced broad national availability of its twist Automated Insulin Delivery (AID) System powered by Tidepool, following clearance by the U.S. Food and Drug Administration in 2024 and a subsequent controlled launch. “With twiist now accessible to more people than ever before, we’ve reached a meaningful milestone for Sequel and for people living with type 1 diabetes,” said Sequel CEO and Co-Founder Alan Lotvin, MD. “twiist was built...
Diabetes advocates rally for Medicare reform on insulin pump access
September 26, 2025Theresa Flaherty
SAN DIEGO – Diabetes stakeholders will meet with CMS in October to urge the agency to update its National Coverage Determination (NCD) guidance on who qualifies for an insulin pump to better reflect current clinical practice.
CMS currently requires a low C-peptide level for insulin pump coverage, which excludes many people with Type 2 diabetes from obtaining an automated insulin delivery (AID) system, even if they were already been benefiting from the technology prior to moving to...
Tandem integrates, partners with Abbott
June 23, 2025HME News Staff
SAN DIEGO – Tandem Diabetes Care has announced that the Tandem t:slimX2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensor. The company has initiated an early access program in the United States and intends to scale availability in the second half of 2025. “Diabetes management is not one-size-fits-all and it is critical for people living with diabetes to be able to personalize...
Tandem backs up efficacy of Mobi
June 25, 2024HME News Staff
SAN DIEGO – Eighty-six percent of participants were satisfied or very satisfied with Tandem Diabetes Care’s Mobi regardless of prior therapy and agreed the automated insulin delivery system improves their quality of life, according to survey results the company presented at the 84th Scientific Sessions of the American Diabetes Association. “These real-world user insights provide evidence that we are furthering our mission to improve the lives of people with diabetes by demonstrating...
Edgepark adds new automated insulin delivery device to portfolio
February 14, 2024HME News Staff
TWINSBURG, Ohio – Edgepark is now offering the newly launched Beta Bionics iLet Bionic Pancreas fully automated insulin delivery (AID) system as part of its comprehensive diabetes management solution portfolio. The iLet does not require carbohydrate counting for carb-aware users and fully automates 100% of insulin doses. Designed for anyone 6 years of age and older living with Type 1 diabetes, it eliminates the traditional manual work previously involved with using an insulin pump. “It’s...